Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aortic Dissection
Cook Medical Enrolls First U.S. Patient in STABLE Aortic Dissection Trial
February 29th, 2008
Cook Medical announced enrollment of the first U.S. patient in the STABLE global clinical trial designed to evaluate the Cook Zenith(R) Dissection Endovascular System for the treatment of Type B thoracic aortic dissections. This is the first device designed specifically to treat aortic dissections, the condition that took the life of actor John Ritter. The technologically advanced device is the first-of-its-kind worldwide and was designed to treat the unique morphology of this disease, a major cause of mortality worldwide. The patient was treated by Joseph Lombardi, M.D., assistant professor at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. Dr....
Source: Health Business Week (2008-02-29)
|
